Review



human il 2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems human il 2
    Human Il 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 925 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Recombinant+Human+IL-2+Protein/pmc13592517-547-23-27
    Average 96 stars, based on 925 article reviews
    human il 2 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trial.
    Article Snippet: Xiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, Li Xie, Chun-Ran Xue, Yi-Shu Wang, Xu-Zhong Pei, Meng-Ze Zhang, Ying Zhang, Wen-Bin Wan, Yan Lin, Ye Deng, Xi-Ying Wang, Yi Chen, He Zhu , Lin-Feng Li, Hui-Ming Xu, Jie Ding, Yi-Fan Wu, Ze Wang, Ya-Ying Song, Kan Wang, Hui-Ying Qiu, Yan Zhou, Yu-Yan Jin, Li-Ping Ni, Jia-Li Yan, Quan Guo, Jia-Hui Xue, Yu-Fang Mei, Bi-Yun Qian3,6, Hao-Jun Yu 1,7,8✉ and Yang-Tai Guan 2✉

    Article Title: Multiplexed high-content imaging uncovers morphological diversity of lymphocyte activation and dysfunction
    Article Snippet: Isolated T cells were cultured in round-bottom 96-well plates or flat-bottom 24-well plates at 1×10 6 cells/mL in StemPro TM 34-SFM (Gibco TM , #10639011) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. .. Unless specified, recombinant human IL-2 (R&D Systems, #10453-IL) was supplemented every two days (15 ng/mL, 140U/mL). .. T cells were activated using ImmunoCultTM Human aCD3/CD28/CD2 T Cell Activator (STEMCELL Technologies TM , #10970) at 12μL per million cells.

    Article Title: Materials and methods relating to immunogenic epitopes from human papilloma virus
    Article Snippet: Transfection of APCs were done using the Lonza 4D Nucleofector, primary P3 buffer, program E0117 (Lonza, MD, USA) and incubated in BCM-10% human serum, IL-4 without any Anti-Anti. .. Twenty four hours later, on day 1, APCs were washed and incubated with thawed whole HPV+ HNSCC PBMCs at a ratio of 1:2 (200,000 APCs: 400,000 PBMCs) in a 24-well plate in BCM supplemented with 20 U/mL recombinant human IL-2 (R&D Systems, MN, USA), 5 ng/mL IL-7 (R&D Systems, MN, USA). ..

    Article Title: Modeling HIV infection, treatment, rebound, and intervention in human immune organoids
    Article Snippet: PBMCs were thawed, and NK cells were isolated by negative selection using NK-negative selection kits (Miltenyi Biotec, #130-092-657). .. NK cells were cultured overnight in R10 medium (RPMI 1640, with 10% FBS, 1% L-glutamine, 1% sodium pyruvate, and 1% PSA Penicillin/Streptomycin/ Actinomycin) supplemented with 300 IU/ml recombinant human IL-2 (R&D Systems) for 18hrs +/- 2hrs. ..

    Article Title: Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack
    Article Snippet: Prior to isolating CD4 + T cells, a non-TC treated sterile 24-well plate (Corning, Inc., Cat.#CLS3738) was coated with 400μL per well of 2μg/mL anti-CD3 antibody (Biolegend, Cat.#317326), diluted in Coating Buffer for at least 2hrs at 37°C, or overnight at 4°C. .. Before plating cells, each well was washed twice with sterile PBS, then given 0.4mL R10 media containing 10ng/mL recombinant human IL-2 (R10/IL-2 Media: IL-2 from R&D Systems, Cat.#202-IL-500). .. CD4 + T cells were isolated from PBMC via negative selection (Stemcell Technologies, Cat.#17952), according to the manufacturer’s instructions.

    Article Title: Selective Immune Silencing by Targeted TGF-β Agonists
    Article Snippet: .. For human in vitro cultures, T cells were plated at 0.75 × 10 6 cells/mL in flat-bottom 12-well plates coated overnight with 5 μg/mL InVivoMAb anti-human CD3 (BE0001, Bio X Cell) and 2.5 μg/mL InVivoMAb anti-human CD28 (BE0248, Bio X Cell) in the presence of 10 ng/mL recombinant human IL-2 (202-IL, R&D Systems) for 3 days. ..

    Article Title: Materials and methods relating to immunogenic epitopes from human papilloma virus
    Article Snippet: APCs were either peptide pulsed with HPV16-epitopes, or transfected with whole HPV-antigen encoded in mammalian expression plasmid pCDNA3.2 (Invitrogen, CA, USA). .. APCs were washed and incubated with thawed whole HPV+ HNSCC PBMCs at a ratio of 1:2 (200,000 APCs: 400,000 PBMCs) supplemented with 20 U/mL recombinant human IL-2 (R&D Systems, MN, USA), 5 ng/mL IL-7 (R&D Systems, MN, USA). ..

    Activation Assay:

    Article Title: Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trial.
    Article Snippet: Xiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, Li Xie, Chun-Ran Xue, Yi-Shu Wang, Xu-Zhong Pei, Meng-Ze Zhang, Ying Zhang, Wen-Bin Wan, Yan Lin, Ye Deng, Xi-Ying Wang, Yi Chen, He Zhu , Lin-Feng Li, Hui-Ming Xu, Jie Ding, Yi-Fan Wu, Ze Wang, Ya-Ying Song, Kan Wang, Hui-Ying Qiu, Yan Zhou, Yu-Yan Jin, Li-Ping Ni, Jia-Li Yan, Quan Guo, Jia-Hui Xue, Yu-Fang Mei, Bi-Yun Qian3,6, Hao-Jun Yu 1,7,8✉ and Yang-Tai Guan 2✉

    other:

    Article Title: O-GlcNAcylation and low glycolysis underpin Th2 polarization by dendritic cells
    Article Snippet: For Th1/2 polarization, 5.000 DCs that were stimulated for 24h were co-cultured with 20.000 allogenic naïve CD4 T cells in the presence of 20 pg/mL Staphylococcal Enterotoxin B (SEB; #S4881, Sigma) in a cell culture treated flat-bottom 96 well plate.

    Incubation:

    Article Title: Materials and methods relating to immunogenic epitopes from human papilloma virus
    Article Snippet: Transfection of APCs were done using the Lonza 4D Nucleofector, primary P3 buffer, program E0117 (Lonza, MD, USA) and incubated in BCM-10% human serum, IL-4 without any Anti-Anti. .. Twenty four hours later, on day 1, APCs were washed and incubated with thawed whole HPV+ HNSCC PBMCs at a ratio of 1:2 (200,000 APCs: 400,000 PBMCs) in a 24-well plate in BCM supplemented with 20 U/mL recombinant human IL-2 (R&D Systems, MN, USA), 5 ng/mL IL-7 (R&D Systems, MN, USA). ..

    Article Title: Materials and methods relating to immunogenic epitopes from human papilloma virus
    Article Snippet: APCs were either peptide pulsed with HPV16-epitopes, or transfected with whole HPV-antigen encoded in mammalian expression plasmid pCDNA3.2 (Invitrogen, CA, USA). .. APCs were washed and incubated with thawed whole HPV+ HNSCC PBMCs at a ratio of 1:2 (200,000 APCs: 400,000 PBMCs) supplemented with 20 U/mL recombinant human IL-2 (R&D Systems, MN, USA), 5 ng/mL IL-7 (R&D Systems, MN, USA). ..

    Cell Culture:

    Article Title: Modeling HIV infection, treatment, rebound, and intervention in human immune organoids
    Article Snippet: PBMCs were thawed, and NK cells were isolated by negative selection using NK-negative selection kits (Miltenyi Biotec, #130-092-657). .. NK cells were cultured overnight in R10 medium (RPMI 1640, with 10% FBS, 1% L-glutamine, 1% sodium pyruvate, and 1% PSA Penicillin/Streptomycin/ Actinomycin) supplemented with 300 IU/ml recombinant human IL-2 (R&D Systems) for 18hrs +/- 2hrs. ..

    Sterility:

    Article Title: Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack
    Article Snippet: Prior to isolating CD4 + T cells, a non-TC treated sterile 24-well plate (Corning, Inc., Cat.#CLS3738) was coated with 400μL per well of 2μg/mL anti-CD3 antibody (Biolegend, Cat.#317326), diluted in Coating Buffer for at least 2hrs at 37°C, or overnight at 4°C. .. Before plating cells, each well was washed twice with sterile PBS, then given 0.4mL R10 media containing 10ng/mL recombinant human IL-2 (R10/IL-2 Media: IL-2 from R&D Systems, Cat.#202-IL-500). .. CD4 + T cells were isolated from PBMC via negative selection (Stemcell Technologies, Cat.#17952), according to the manufacturer’s instructions.

    In Vitro:

    Article Title: Selective Immune Silencing by Targeted TGF-β Agonists
    Article Snippet: .. For human in vitro cultures, T cells were plated at 0.75 × 10 6 cells/mL in flat-bottom 12-well plates coated overnight with 5 μg/mL InVivoMAb anti-human CD3 (BE0001, Bio X Cell) and 2.5 μg/mL InVivoMAb anti-human CD28 (BE0248, Bio X Cell) in the presence of 10 ng/mL recombinant human IL-2 (202-IL, R&D Systems) for 3 days. ..



    Similar Products

    96
    Miltenyi Biotec recombinant human il 2
    Recombinant Human Il 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Human+IL-2+IS%2C+research+grade/pmc13682394-34-75-79
    Average 96 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    MedChemExpress recombinant human il 2 protein
    Recombinant Human Il 2 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/IL-2%2C+Human/pmc13389675-136-27-31
    Average 93 stars, based on 1 article reviews
    recombinant human il 2 protein - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc human il 2
    Human Il 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Human+IL-2+Recombinant+Protein/pm42881259-201-24-26
    Average 93 stars, based on 1 article reviews
    human il 2 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Proteintech il 2
    Il 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Animal-free+Recombinant+Human+IL-2/pm42852629-70-55-56
    Average 94 stars, based on 1 article reviews
    il 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    R&D Systems human il 2
    Human Il 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Recombinant+Human+IL-2+Protein/pmc13592517-547-23-27
    Average 96 stars, based on 1 article reviews
    human il 2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Proteintech recombinant human il 2
    Recombinant Human Il 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Animal-free+Recombinant+Human+IL-2/10__1007_slash_s00262___026___04553___2-58-16-19
    Average 94 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology recombinant human il 2
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Recombinant Human Il 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Recombinant+Human+IL2+Protein/pmc13460283-253-0-5
    Average 94 stars, based on 1 article reviews
    recombinant human il 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec human recombinant il 2
    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined <t>by</t> <t>IL‐2</t> production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.
    Human Recombinant Il 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+2/Human+IL-2+IS%2C+research+grade/pmc13660164-72-6-10
    Average 96 stars, based on 1 article reviews
    human recombinant il 2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined by IL‐2 production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.

    Journal: Advanced Science

    Article Title: Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy

    doi: 10.1002/advs.77020

    Figure Lengend Snippet: Assessment of auxCAR‐T cell performance in Jurkat T cells. (A,B) Representative Flow cytometry (A) and Statistical quantification (B) of early T cell activation as reflected by upregulated CD69 expression on the cell surface. Jurkat T cells transduced with stCAR (left) and auxCAR (right) were co‐cultured with hCD19 + Raji cells or hCD19 − K562 cells, with or without auxin. n = 3 independent biological replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (C,D) Statistical quantification of NFAT‐GFP reporter activity in Jurkat T cells expressing stCAR and auxCAR co‐cultured with tumor cells with hCD19 + Raji cells (C) or A431‐CD19 (D) with the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). The p ‐values were calculated using one‐way analysis of variance (ANOVA). (E) Auxin‐dose‐dependent responses of stCAR T and auxCAR‐T cells examined by IL‐2 production in Jurkat T cells. (F) Architecture of the auxCAR HER2. Upper: cartoon depicting the different components. Bottom: schematic of the R‐ and S‐chains encoded in a single lentiviral vector, each separated by Venus or mScarlet. (G,H) Statistical quantification of NFAT‐GFP reporter activity (G) and IL‐2 production (H) in Jurkat T cells expressing stCAR HER2 or auxCAR HER2 co‐cultured with SK‐OV‐3 tumor cells in the presence of the indicated auxin concentration. n = 3 independent technical replicates (mean ± s.d.). (I) Statistical quantification of NFAT‐GFP reporter activity at the indicated time points following auxin removal in Jurkat T cells expressing auxCAR and co‐cultured with SK‐OV‐3 tumor cells. The auxCAR T cells were induced with 1 µM auxin.

    Article Snippet: Recombinant human IL‐2 (Cat# RP01039, ABclonal) was added at a final concentration of 100 Unit/mL −1 to expand T cells.

    Techniques: Flow Cytometry, Activation Assay, Expressing, Transduction, Cell Culture, Activity Assay, Concentration Assay, Plasmid Preparation